Regeneron Pharmaceuticals Inc. buy Sanford C. Bernstein
Summary
This prediction is currently active. Since the start of the prediction for Regeneron Pharmaceuticals Inc. the price has only changed by 0.32%. This prediction currently runs until 08.04.27. The prediction end date can be changed by Sanford_C__Bernstein at any time. Sanford_C__Bernstein has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Regeneron Pharmaceuticals Inc. | 0.32% |
| iShares Core DAX® | 0.231% |
| iShares Nasdaq 100 | 1.663% |
| iShares Nikkei 225® | -0.208% |
| iShares S&P 500 | 1.067% |
Comments by Sanford_C__Bernstein for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Stopped prediction by Sanford_C__Bernstein for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
27.08.25
27.08.26
17:03
Regeneron Pharmaceuticals Inc.
07.01.25
07.01.26
08.01.26
Regeneron Pharmaceuticals Inc.
12.03.24
12.03.25
13.03.25

